Linking Medical Product Manufacturing Locations with Natural Hazard Risk: Implications for the Medical Product Supply Chain

This ASPE data point links manufacturer location data with the Federal Emergency Management Agency (FEMA) National Risk Index (NRI), which describes relative risk of experiencing a variety of natural hazards in order to highlight the ways in which natural disasters may pose supply chain vulnerabilities within the U.S. We found that drug and device manufacturers are disproportionately located in areas of high risk of natural hazards such as tornados, earthquakes, hurricanes, and other extreme weather events. This analysis is exploratory and represents a potential approach to linking natural disaster and climate change risk with supply chain vulnerabilities.

*This content is in the process of Section 508 review. If you need immediate assistance accessing this content, please submit a request to Allison Kolbe, allison.kolbe@hhs.gov. Content will be updated pending the outcome of the Section 508 review.

Related Products:

• Medical Product Shortages in the United States: Demographic and Geographic Factors and Impacts
• Policy Considerations to Prevent Drug Shortages and Mitigate Supply Chain Vulnerabilities in the United States